Macimorelin (Ghryvelin)
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- July 2022
Comments
60mg granules for oral suspension in sachet. Diagnosis of growth hormone
deficiency in adults. ICB commissioned.Black Drug Classifications
- 1: Are classified by the BNF as 'less suitable for prescribing', and includes anti-malarials (where a private prescription may be provided). Have a lack of data on effectiveness compared with standard therapy
search again